EP0538450A4 - - Google Patents

Info

Publication number
EP0538450A4
EP0538450A4 EP19920911615 EP92911615A EP0538450A4 EP 0538450 A4 EP0538450 A4 EP 0538450A4 EP 19920911615 EP19920911615 EP 19920911615 EP 92911615 A EP92911615 A EP 92911615A EP 0538450 A4 EP0538450 A4 EP 0538450A4
Authority
EP
European Patent Office
Prior art keywords
bag
sensor
microbial growth
blood
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920911615
Other versions
EP0538450A1 (en
Inventor
Roger J. Morris
Calvert Lawrence Green
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare Corp
Original Assignee
Baxter Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Diagnostics Inc filed Critical Baxter Diagnostics Inc
Publication of EP0538450A1 publication Critical patent/EP0538450A1/en
Publication of EP0538450A4 publication Critical patent/EP0538450A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor

Definitions

  • This invention relates to a noninvasive method and apparatus to detect the presence or determine the concentration of microorganisms in a container of transfusable blood prior to transfusion.
  • Microorganisms present in bodily fluid can be detected using a culture bottle.
  • a culture bottle is a flask allowing positive cultures to be detected rapidly.
  • the flask is generally a transparent closed container filled with nutrient that promotes the growth of the organism.
  • bacteria in blood can be detected in culture.
  • U.S. Patent No. 4,772,55_A-(Hammann) . Many different qualitative and quantitative detection means are used to monitor the growth of microorganisms in a culture bottle.
  • the microorganisms in a culture bottle have been detected by use of external detectors such as a magnifying lens, U.S. Patent No. 4,543,907 (Freudlich) .
  • liquid level indicators can show bacterial growth as a function of increased pressure in the vessel.
  • microorganisms can be detected by measuring changes in pH caused by bacterial growth, Mariel, G.B. Patent No. 1,601,689.
  • Still another method to detect microorganisms involves the use of a culture media that contains a compound which changes color or appearance according to the growth of microorganisms.
  • the change in the media can be detected with a spectrophotometer.
  • Bascomb Enzyme Tests in Bacterial Identification, Meth. Microbiol. 19 . , 105 (1987) .
  • a variety of organisms can be classified in large part by their pattern of fermentation, oxidation or assimilation of carbon sources. Fermentation of carbohydrates results in the production of acid which causes a decrease in pH. This drop in pH can be easily detected by including a pH indicator like bromthymol blue or phenol red.
  • Chemical and enzymatic reactions are used to detect or quantitate the presence of certain substances in microbiological or other assays. Many of these tests rely on the development or change of color or fluorescence to indicate the presence or quantity of the substance of interest.
  • Another approach to determine if an organism can degrade a particular substrate is to use a reagent which is capable of reacting with one or more of the intermediates or final products. For example, the detection of the reduction of nitrate to nitrite. If nitrite is formed, then a pink to deep red color will result when sulfanilic acid and alpha-naphthylamine are added to the reaction mixture.
  • a synthetic analog of a natural substrate can be used directly indicate the presence of an enzyme.
  • methylene blue can be reduced under certain conditions by the action of reductase, resulting in a shift from blue to colorless.
  • the oxidase assay relies on the interaction of cytochrome oxidase with N, N, N' , N l -tetramethyl- / /-phenylene-diamine producing a blue color.
  • Another example is the ability of microorganisms to degrade sulfur-containing a ino acids as indicated by the production of H 2 S.
  • the organism is incubated with a high concentration of a sulfur-containing substrate (e.g. cysteine, cystine) in an acid environment.
  • a sulfur-containing substrate e.g. cysteine, cystine
  • the production of H 2 S is indicated by the formation of a black precipitate in the presence of ferric ammonium citrate.
  • Enzymes can usually act on more than one substrate. This allows for the use of synthetic enzyme substrates for the detection of enzyme activities.
  • Synthetic substrates contain a metabolic moiety conjugated with a chromatic or fluorescent moiety.
  • the conjugated molecule usually has a different absorption and/or emission spectrum from the unconjugated form.
  • the unconjugated chromatic or fluorescent moiety shows a considerably higher absorption or fluorescence coefficients than those of the conjugated molecule.
  • An example of a synthetic enzyme substrate ⁇ is _-nitro-phenol-jS-galactopyranoside used for the detection of activity of the enzyme .-galactosidase.
  • the conjugated substrate is colorless.
  • the 3-galactosidase enzyme hydrolyzes the substrate to yield /_-galactosidase and t-nitro-phenol.
  • Bascomb, Enzyme Tests in Bacterial Identification, Meth. Microbiol. JL9 . , 105 (1987) reviewed the synthetic moieties used for enzyme substrates and the enzymatic activities measurable using this principle.
  • the monitoring of color or color end-product in chemical and microbial reactions is usually achieved in either of two ways; 1) the detection of color or color end-product can be achieved by visual observation and estimated qualitatively, or 2) the detection of color end-products or loss of color can be achieved by measuring the intensity of color instru entally.
  • Spectrophotometers that measure light absorbance are commonly used for this purpose. When measuring the concentration of a number of substances it is advantageous to use one instrument based on one principle of measurement, otherwise cost is increased. Although the use of colorimetric reactions is widespread there are limitations, especially in the sensitivity of detection. In order to improve sensitivity and, in the case of identification of microorganisms, thereby to decrease the time required to obtain a result, fluorescence-based methods frequently are used. Unfortunately, it may not be possible to develop a fluorescent equivalent to every assay. Additionally, the fluorescent reagents , themselves may be highly toxic and therefore difficult to commerciali,ze.
  • the general principle of fluorescence quenching has been accepted as a way to detect or determine enzymatic or chemical reactions.
  • Fleminger et al. synthesized intramolecularly quenched fluorogenic substrates for the assay of bacterial aminopeptidase
  • P. Fleminger et al. Fluoroqenic Substrates for Bacterial Aminopeptidase P and its Analog's Detected in Human Serum and Calf Lung. Eur. J. Biochem. 125, 609 (1982) .
  • the fluorescence of the aminobenzoyl group is quenched by the presence of a nitrophenylalanyl group.
  • Enkephalinase a Neutral Metalloendopeptidase that Releases Tyrosine-Glvcine-Glvcine from Enkephalins, Anal. Biochem. 141, 62 (1984) .
  • a synthetic substrate containing a quenching group and a fluorescing group was generated in order to detect the activity of the enzyme.
  • An alternative to this approach would involve the synthesis of a resonance energy transfer pair of fluorescing groups on a substrate molecule. In this method, cleavage by the enzyme of one of the groups would result in a decrease in fluorescence, since the critical distance would be exceeded, eliminating the transfer of energy.
  • the previously discussed approaches are limited to specifically designed substrates.
  • Still another approach involves the estimation of a chromophore by fluorescence measurement. See . Blu berg et al. , Hemoglobin Determined in Whole Blood "Front Face” Fluorometry, Clin. Hemo. 2 _, 409 (1980) . Blumberg disclosed an assay based on attenuation of fluorescence of a dye, whose excitation wavelengths overlap with the absorption wavelengths of the chromophore.
  • Shaffer U.S. Patent No. 4,495,293
  • Shaffer filed a patent application disclosing a method to fluorometrically determine a ligand in an assay solution using conventional fluoro etric techniques.
  • the intensity of the fluorescence emitted by the assay > solution is related to the change in trans issive properties of the assay solution produced by the interaction of ; the ligand to be determined and a reagent system capable of producing change in the transmissive properties of the assay solution in the presence of the ligand.
  • Shaffer discloses a method to monitor absorbance using a fluorophore in solution with the chromophore.
  • the fluorophore may interact with the assay cocktail and produce changes in fluorescence intensity which are unrelated to the change being measured.
  • the selection of the fluorophores is also restricted, in that pH dependent or environment sensitive fluorophores cannot be utilized. Additionally, when the fluorophore is in solution, less than accurate measure of absorbance may be obtained because light is absorbed exponentially through the chromophore sample.
  • Beggs & Sand, EPA 91,837 disclosed a solution based method for determination of tryptophan-deaminase activity by measuring the reduction in fluorescence in the presence of a chromophore produced by the interaction between indole pyruvic acid and metal ions using a fluorophore "whose fluorescence is capable of being quenched by the indole pyruvate-metal ion complex, the ions of the fluorophore being present throughout the incubation period".
  • Sands, U.S. Patent No. 4,798,788 discloses a process to detect a nitrate reducing microorganism by measuring reduction of fluorescence in solution by causing the diazotization of the fluorophore.
  • a specific fluorophore needs to be chosen for each test to ensure that it will fluoresce under the conditions of the test, e.g. only few fluorophores fluoresce at pH of ,less than 2.0.
  • the previously discussed blood culture test can be used to determine bacterial contamination of transfusable blood, these test may result in errors.
  • the transfusion bag must be later matched with a separate blood culture bottle sent to a test center to make a determination of potential microbial contamination prior to transfusion of the blood. This requirement for subsequent matching could result in errors.
  • blood culture bottles are cultured at higher temperature than the temperature that blood is normally stored; as such blood culture bottle tests yield an accelerated picture of bacterial contamination, while a test that simulates actual blood storage conditions may yield more accurate results.
  • This invention relates to a multi-layer body fluid culture sensor comprised of a pH sensitive absorbance based dye spectrally coupled to a pH insensitive, or pH sensitive dye that is highly buffered, fluorescence based dye.
  • the pH sensitive absorbance based dye is encapsulated or isolated in a polymeric layer that is permeable to C0 2 and water, but impermeable to protons.
  • the pH insensitive fluorophore is encapsulated or isolated in the second polymeric layer that may or may not be permeable to C0 2 and water.
  • This type of sensor may be used to detect or determine the concentration of , microorganisms in bodily fluid.
  • the spectral criterion required to make this determination are such that the absorption spectrum of the chromophore must overlap the excitation and/or emission spectrum of the fluorophore, thereby allowing the change in fluorescence to be related to the change in the reaction and consequently related to the presence or quantity of the substance of interest.
  • this sensor is used to monitor microbial growth in collected transf sable blood.
  • this sensor can be used to monitor bacterial growth in a collection bag of bodily fluid that is to be transfused into a patient.
  • bacteria grow they generate C0 2 .
  • the C0 2 generated by the bacteria diffuses into the polymeric layer that is in direct contact with a hydrated pH sensitive absorbance based dye.
  • the C0 2 reacts with the aqueous environment to form carbonic acid (H 2 C0 3 ) , which lowers the pH of the absorbance dye environment. This results in a concomitant change in the pH sensitive spectrum of the dye.
  • the senor is attached to a blood collection bag or separate sampler test bag. If a separate sampler bag is used this bag may contain microbial growth media or an inert substance such as a saline. With this system microbial contamination of transfusable blood in a collection bag can be determined immediately prior to transfusion.
  • a detector such as a handheld fluorescence detector, is used to monitor the - emitted fluorescence.
  • Fig. 1 shows a schematic diagram of a multi-layer blood culture sensor.
  • Fig.2 shows a blood culture growth curve detected by a xylenol blue-rhodamine 101 sensor.
  • Fig. 3 shows a blood culture growth curve detected by xylenol blue in silicone-rhodamine B in acrylic sensor.
  • Fig. 4 shows a blood culture growth curve for a xylenol blue in silicone-6213 acrylic sensor.
  • Fig. 5 shows a blood culture growth curve for a bromthymol blue in silicone-rhodamine 101 in silicone sensor.
  • Fig. 6 shows a sample test blood collection bag and fluorescent detector for monitoring growth of microorganisms in blood.
  • Fig. 7 shows the percent change of fluorescent intensity versus time for two blood samples.
  • fluorescence from a fluorophore embedded in an inert light-transparent matrix is modulated by a pH sensitive absorbance dye embedded in a polymeric gas permeable, but proton impermeable matrix.
  • the assay is carried out in a blood collection bag or sampler test blood collection bag.
  • fluorometric based colorimetric assay the fluorescence intensity is regulated by changes in absorbance of an interfering chromophore. As a pH change occurs the chromophoric material alters the ,amount of emitted light reaching the fluorophore and/or the amount of emitted light reaching the detector.
  • Spectrally compatible fluorescent and colorimetric indicators are selected so that as the pH changes due to the production of CO- by microorganisms present in the blood, the colorimetric indicators regulate the amount of light reaching the fluorophore and/or photodetector and, thus cause a change in the excitation and/or emission of the fluorescent dye. This change is detected with a fluorescent reader and can be correlated with the presence or concentration of microorganisms in the blood.
  • a bodily fluid culture sensor is comprised of a pH sensitive absorbance based dye in or isolated by a polymeric gas permeable, but proton impermeable matrix, and a fluorescent dye in a second polymeric matrix.
  • Spectrally compatible fluorescent and colorimetric indicators are selected so that when an organism is present in blood, the colorimetric indicator will regulate the amount of light reaching the fluorophore thereby causing a change in the emission intensity from the fluorescence dye reaching the photodetector.
  • the change indicating the presence of bacteria, is detected with a fluorometric reader.
  • spectrally compatible fluorescence and absorbance dyes are selected dyes are selected so that as carbonic acid is produced (C0 2 and H 2 0) , the absorbance of the dye will change thereby regulating the amount of light reaching the fluorophore and/or photodetector, thus producing a change in the measured fluorescence. This change is detected with a fluorescence reader.
  • Spectrally compatible dyes are rhodamine B and xylenol blue.
  • bromthymol blue and rhodamine 101 are also spectrally compatible. For example this can be illustrated by inoculating a bag containing the appropriate growth media with Yersinia enterocolitica. As the organism grows, it produces C0 2 gas.
  • the silicone is permeable to the C0 2 .
  • the C0 2 diffuses to the absorbance layer and reacts with water to produce carbonic acid (H 2 C0 3 ) .
  • the carbonic acid causes a drop in the pH in the absorbance dye environment resulting in a change in measured absorbance. For example, as the pH drops in an absorbance layer containing the dye xylenol blue, the absorbance of xylenol blue decreases, thereby allowing more light to reach the fluorophore to excite it and thus increase the amount of fluorescence emitted at 590nm.
  • a positive culture using xylenol blue as the absorbance dye is detected by increase the amount of fluorescence emitted at 590nm.
  • a positive culture using xylenol blue as the absorbance dye is detected by a measured increase in fluorescence as the xylenol blue decreases in absorbance See Fig. 7.
  • the pH sensitive absorbance based dye is encapsulated in or isolated by a polymeric matrix that is gas permeable, but proton impermeable.
  • the polymeric matrix must be optically transparent in the visible region, permeable to gas, autoclavable, stable for at least six months, and proton impermeable.
  • silicone may function as the polymeric matrix used to encapsulate or isolate the absorbance - based dye. Silicones found to meet these criteria , were Dow, Rhone Poulenc, G.E. and Wacker.
  • the fluorescence based dyes can also be encapsulated in a polymeric matrix.
  • the polymeric matrix used for the fluorophore does not have to meet all of the above requirements listed for the matrix used to encapsulate or isolate the absorbance dye.
  • the similar features that it must possess are that it must be optically transparent in the visible region, autoclavable and stable for at least six months.
  • the polymeric matrix containing or isolating the absorbance based dye must be coupled to the polymeric matrix containing the fluorescent dye. It should be noted that the polymeric matrices must be in close proximity so that light that has been regulated by the absorbance layer will have an effect on the emission intensity of the fluorophore as received by the photodetector.
  • a microorganism growth monitoring system for collected transfusable blood is shown in Fig. 6.
  • the monitoring system shown in Fig. 6 is comprised of a sampler test blood collection bag 20.
  • a bar code 28 can be attached to the bag to record data for later inspection. Blood from the blood collection bag to be transfused is expressed through tube 24 to sampler test blood collection bag 20.
  • the wall of the blood collection bag contains a multi-layer sensor 22 .comprising a pH sensitive dye in a light transmissive, gas permeable, proton impermeable matrix and a pH insensitive fluorescence dye in inert light transparent matrix, said first and second matrices being spectrally coupled.
  • the blood collection or blood storage bag can contain whole blood, plasma, serum, erythrocytes, red blood corpuscles, leukocytes, white blood corpuscles, thrombocytes and blood platelets, collectively referred to as blood storage.
  • the sensor can be located on the interior wall of the blood collection bag or a separate sampler test blood collection bag to which blood can be shunted for assessment. These various types of bags are heretofore collectively referred to as blood collection bag.
  • the bag may contain a growth media or an inert substance such as saline.
  • the two-layer sensor is mounted inside a blood collection bag such that one layer, of the sensor is positioned facing outside the bag.
  • the second layer which is fluorescent is positioned facing the interior of the bag.
  • the sensor may be formed integrally with the wall of the bag.
  • the invention is comprised of the two-layer sensor outlined above, mounted inside a blood collection container in such a way that by utilizing a fluorometer to excite the fluorescent sensor and detect the emitted fluorescent light, a determination can be made as to the presence of a threshold level of microorganisms contained within the blood collection container.
  • An additional feature of this invention is ; that the bag is stored at normal blood storage temperatures, i.e. 4°C.
  • certain microorganisms are not affected by the cold: Yersinia enterocolitica and Enterobacter agglomerans.
  • the system allows for the determination of other bacteria that would not normally grow rapidly in the cold but might be present in such high concentrations over time that it would be unsafe to transfuse into a patient: Citrobacter freundii; Pseudomonas aeruginosa; Staphylococcus aureus; and staphylococcus epidermidis.
  • An alternative approach would follow the same design but would consist solely of an absorbance sensor.
  • Another feature of this invention involves covering the sensor with a gas permeable membrane to prevent naturally fluorescing substances in the blood from interacting with the fluorescent measurement.
  • a bodily fluid culture sensor is comprised of a pH sensitive absorbance based dye encapsulated in or isolated by a polymeric gas permeable, but proton impermeable matrix 4 and a fluorescent dye in a second polymeric matrix 2.
  • Reflective surface 6 can be included to facilitate the transmission of light to the detecting element 12.
  • interrogation light enters the sensor and is regulated by pH sensitive matrix 2 which in turn causes a change in ' the fluorescence emission 10 of the fluorophore in .matrix 4. This sensor offers the advantage of maximal surface.area.
  • a measurement is taken by first reading reference light intensity. Next the reading from the sensor disk is measured. The data is plotted by taking the ratio of reference, excitation light, to sample. In particular, as C0 2 levels increase in the blood collection bag, the absorbance of the absorbance dye changes, thereby changing the amount of light reaching the fluorescence layer and/or photodetector. This causes a change in emitted fluorescence that is detected.
  • the following examples serve to illustrate the method of the present invention. The concentration of reagents and other variable parameters are only shown to exemplify the methods of the present invention and are not to be considered limitation thereof.
  • an additional amount (10ml) is collected in such a manner as to be subsequently sectioned off from the unit to be transfused.
  • This additional blood is then expressed through a tube into a flexible bag, attached to the blood collection bag.
  • This side bag is supplied containing a microorganism growth media and an attached multi-layer sensor.
  • the sensor is capable of detecting microorganism growth by measuring an increase in C0 2 production through a change in fluorescence emitted from the sensor.
  • an initial reading of the - sensor is made using a portable handheld fluorometer / to produce a baseline fluorescence level. This level can be manually , recorded for latter comparison or a bar code can be provided and attached to the bag.
  • the blood and additional monitoring bag are then stored in a normal manner (4°C) .
  • a second reading of the sensor is made and compared to the first reading. This is compared to the original reading. If a bar code was produced, the bar code and sensor are read.
  • the instrument will compare the initial and final fluorescent values and based upon an established threshold level of change will signal negative or positive for growth. In this particular embodiment, the instrument will signal green for no growth or red for growth based on differences in original and final sensor readings.
  • Wacker silicone elastomer 3601 part A is thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended by the manufacturer.
  • the absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55"C for 2 hours.
  • Wacker silicone is prepared, as described above. Next 2% w/w of 7.5mM Rhodamine 101, in 50mM Tris-HCl buffer pH 8.5 in 95% ethylene glycol, is added to the silicone. The mixture is poured over the previously cured xylenol blue layer in the mold, - described above, and cured at 55°C overnight.
  • This __ured, dehydrated, double layer sensor consists of two distinct layers., each 30/1000 of an inch thick. Disks may now be punched out of the mold and adhered onto the base of bottles using more silicone, ensuring that the absorbance layer is face down.
  • bottles are cured at 55°C for 15 minutes, rehydrated with normal saline and autoclaved on the wet cycle for 17 minutes.
  • Saline is replaced with growth media and inoculated with E. coli by injecting a suspension with a sterile needle through the septum.
  • the blood culture bottle is placed in the instrument and fluorescence emission is measured.
  • the pH sensitive absorbance dye, Xylenol blue As the concentration of C0 2 increases in the blood culture bottle, the pH sensitive absorbance dye, Xylenol blue, the absorbance of the dye decreases, thus allowing more light to reach the fluorophore, Rhodamine 101, to thus increase the amount of fluorescence emitted at 590nM. This increase in fluorescence intensity v. time is shown in the blood culture growth curve at Fig. 2.
  • Rhone Poulenc silicone elastomer 141 part A is thoroughly mixed with Rhone Poulenc 141 catalyst part B in a 10:1 ratio, as recommended by the manufacturer.
  • the absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch. The mold is allowed to sit out on the countertop at room temperature for about one hour or until the bubbles have disappeared, at which time the mold is placed in the incubator to cure at 55°C for two hours.
  • Rhone-Poulenc silicone is prepared, as described above. Next, a 40/1,000" thick acrylic disc (Glasflex, Inc.), approximately 1 cm in diameter, containing 0.2 grams/lb of rhodamine B (Sigma) is glued onto the above absorbance layer using the Rhone-Poulenc Silicone at the 10:1 ratio as glue. The double layer sensor is then placed back in the 55°C incubator for two hours to allow for adherence of the two layers. Following the curing, the double layer sensor is punched out with a cork borer, and glued onto the base of a Wheaton bottle, ensuring that the absorbance layer is face down, using the Rhone Poulenc silicone as mentioned above. The bottle is placed in the 55°C incubator to cure for at least two hours. The bottle is then rehydrated overnite and tested the following day as described in Example 1.
  • Example 4 Xylenol Blue in Silicone/6213 Red Standard Acrylic Wacker silicone elastomer 3601 part A is thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended with Wacker 3601 catalyst - part B in a 9:1 ratio, as recommended by the manufacturer. Next 5% w/w of a 50mM xylenol blue, dissolved in 5mM borate buffer pH 11 containing 1%
  • Tween 80 is added to the silicone and homogenized to ensure a uniform distribution of the dye.
  • the absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55"C for two hours.
  • a 40/1,000" thick acrylic disc (Glasflex, Inc.) , approximately 1 cm in diameter, referred to as No. 6213 Red (Glasfle:* Standard Product) is glued onto the above absorbance layer using the Wacker silicone at the 9:1 ratio as glue.
  • the double layer sensor is then placed back in the 55"C incubator for two hours to allow for adherence of the two layers.
  • the double layer sensor is punched out with a cork borer, and glued onto the base of a Wheaton bottle, ensuring that the absorbance layer is face down, using the Rhone Poulenc silicone as mentioned above.
  • the bottle is placed in the 55°C incubator to cure for at least two hours.
  • the bottle is then rehydrated overnite and tested the following day as described in Example 1.
  • Wacker silicone elastomer 3601 part A is thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended by the manufacturer.
  • 5% w/w of 50mM bromthymol blue, dissolved in 5mM tris buffer pH 12 in ethylene glycol, is added to the silicone and homogenized to ensure a uniform distribution of the dye.
  • the absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55°C for two hours.
  • Wacker silicone is prepared, as described above.
  • 2% w/w of 7.5mM Rhodamine 101 in 50mM Tris-HCl buffer pH 8.5 in 95% ethylene glycol, is added to the silicone.
  • the mixture is poured over the previously cured xylenol blue layer in the mold, described above to isolate the absorbance layer.
  • This sensor is then cured at 55°C overnight.
  • This cured, dehydrated, double layer sensor consists of two distinct layers, each 30/1000 of an inch thick. Disks may now be punched out of the mold and adhered onto the base of bottles using more silicone, ensuring that the absorbance layer is face down.
  • the bottles are cured at 55"C for 15 minutes, rehydrated with normal saline and autoclaved on the wet cycle for 17 minutes. Saline is replaced with growth media and inoculated with E. coli by injecting a suspension with a sterile needle through the septum.
  • the blood culture bottle is placed in the instrument and fluorescence emission is measured. The increase in fluorescence intensity v. time is shown in blood culture growth curve in Fig. 5.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a growth monitoring apparatus for collected transfusable bodily fluids. In particular the apparatus involves a flexible blood collection bag (20) or a sample bag (20) containing microbial growth media. A sensor (22) attached to the inside wall of the bag (20) is used to noninvasively detect microbial contamination within the bag (20). This invention also relates to a method to detect microbial growth in a blood collection bag (20) immediately prior to transfusion.

Description

METHOD AND APPARATUS TO DETECT BACTERIAL CONTAMINATION OF TRANSFUSABLE BLOOD
This is a continuation-in-part of U.S. Patent Application Serial No. 07/638,481, filed January 4, 1991; which is in turn a continuation-in-part of U.S. Patent Application Serial No. 07/609,278, filed November 5, 1990.
Field of the Invention This invention relates to a noninvasive method and apparatus to detect the presence or determine the concentration of microorganisms in a container of transfusable blood prior to transfusion.
Background of the Invention Microorganisms present in bodily fluid can be detected using a culture bottle. Generally, a culture bottle is a flask allowing positive cultures to be detected rapidly. The flask is generally a transparent closed container filled with nutrient that promotes the growth of the organism. In particular, bacteria in blood can be detected in culture. U.S. Patent No. 4,772,55_A-(Hammann) . ; Many different qualitative and quantitative detection means are used to monitor the growth of microorganisms in a culture bottle. The microorganisms in a culture bottle have been detected by use of external detectors such as a magnifying lens, U.S. Patent No. 4,543,907 (Freudlich) . Additionally, internal detectors such as liquid level indicators can show bacterial growth as a function of increased pressure in the vessel. Swaine et al. , EPA 124,193. Additionally, microorganisms can be detected by measuring changes in pH caused by bacterial growth, Mariel, G.B. Patent No. 1,601,689.
Still another method to detect microorganisms involves the use of a culture media that contains a compound which changes color or appearance according to the growth of microorganisms. The change in the media can be detected with a spectrophotometer. There are many examples of reactions used in Microbiology that rely on a color change. Bascomb, Enzyme Tests in Bacterial Identification, Meth. Microbiol. 19., 105 (1987) . For example, a variety of organisms can be classified in large part by their pattern of fermentation, oxidation or assimilation of carbon sources. Fermentation of carbohydrates results in the production of acid which causes a decrease in pH. This drop in pH can be easily detected by including a pH indicator like bromthymol blue or phenol red. With both indicators, acid conditions representing the fermentation of a particular carbohydrate result in a < yellow color (changing from blue-green for bromthymol t blue or pink/red for phenol red) . The same approach can be adopted,for a variety of carbohydrates, ranging from onosaccharides like glucose to polysaccharides like inulin. In an analogous fashion, increasing pH can be also be monitored. Assays for detecting the presence of decarboxylase and urease, and the ability to use malonate are based on an increase in pH, as indicated by a color change in the indicator. Turner, et al. U.S. Patent No. 4,945,060 discloses a device for detecting microorganisms. In this device changes in the indicator medium resulting from pH changes in C02 concentration in the medium are detected from outside the vessel.
Chemical and enzymatic reactions are used to detect or quantitate the presence of certain substances in microbiological or other assays. Many of these tests rely on the development or change of color or fluorescence to indicate the presence or quantity of the substance of interest. Another approach to determine if an organism can degrade a particular substrate, is to use a reagent which is capable of reacting with one or more of the intermediates or final products. For example, the detection of the reduction of nitrate to nitrite. If nitrite is formed, then a pink to deep red color will result when sulfanilic acid and alpha-naphthylamine are added to the reaction mixture. In contrast to the indirect detection of an enzymatic reaction illustrated by the nitrate/nitrite ; test, it is possible to use a synthetic analog of a natural substrate to directly indicate the presence of an enzyme. For example, methylene blue can be reduced under certain conditions by the action of reductase, resulting in a shift from blue to colorless. In another test, the oxidase assay relies on the interaction of cytochrome oxidase with N, N, N' , Nl-tetramethyl-//-phenylene-diamine producing a blue color. Another example is the ability of microorganisms to degrade sulfur-containing a ino acids as indicated by the production of H2S. Typically, the organism is incubated with a high concentration of a sulfur-containing substrate (e.g. cysteine, cystine) in an acid environment. The production of H2S is indicated by the formation of a black precipitate in the presence of ferric ammonium citrate. Enzymes can usually act on more than one substrate. This allows for the use of synthetic enzyme substrates for the detection of enzyme activities. Synthetic substrates contain a metabolic moiety conjugated with a chromatic or fluorescent moiety. The conjugated molecule usually has a different absorption and/or emission spectrum from the unconjugated form. Moreover, the unconjugated chromatic or fluorescent moiety shows a considerably higher absorption or fluorescence coefficients than those of the conjugated molecule. This allows the measurement of small amounts of products of enzyme activities in the presence of the large amounts of conjugated substrate required for maximal enzyme • activity. An example of a synthetic enzyme substrate ^is _-nitro-phenol-jS-galactopyranoside used for the detection of activity of the enzyme .-galactosidase. The conjugated substrate is colorless. The 3-galactosidase enzyme hydrolyzes the substrate to yield /_-galactosidase and t-nitro-phenol. e—nitro-phenol absorbs strongly at 405nm, and its release can be measured by the increase in absorbance at that wavelength. Bascomb, Enzyme Tests in Bacterial Identification, Meth. Microbiol. JL9., 105 (1987) , reviewed the synthetic moieties used for enzyme substrates and the enzymatic activities measurable using this principle.
Presently, the monitoring of color or color end-product in chemical and microbial reactions is usually achieved in either of two ways; 1) the detection of color or color end-product can be achieved by visual observation and estimated qualitatively, or 2) the detection of color end-products or loss of color can be achieved by measuring the intensity of color instru entally.
Spectrophotometers that measure light absorbance are commonly used for this purpose. When measuring the concentration of a number of substances it is advantageous to use one instrument based on one principle of measurement, otherwise cost is increased. Although the use of colorimetric reactions is widespread there are limitations, especially in the sensitivity of detection. In order to improve sensitivity and, in the case of identification of microorganisms, thereby to decrease the time required to obtain a result, fluorescence-based methods frequently are used. Unfortunately, it may not be possible to develop a fluorescent equivalent to every assay. Additionally, the fluorescent reagents , themselves may be highly toxic and therefore difficult to commerciali,ze.
In such cases one might need to measure activities of some enzymes fluorometrically, the others colorimetrically However, most instruments are suited to measure either absorbance or fluorescence, and very few can be used to measure both.
The general principle of fluorescence quenching has been accepted as a way to detect or determine enzymatic or chemical reactions. For example, Fleminger et al. synthesized intramolecularly quenched fluorogenic substrates for the assay of bacterial aminopeptidase, P. Fleminger et al., Fluoroqenic Substrates for Bacterial Aminopeptidase P and its Analog's Detected in Human Serum and Calf Lung. Eur. J. Biochem. 125, 609 (1982) . In this case, the fluorescence of the aminobenzoyl group is quenched by the presence of a nitrophenylalanyl group. When the enzyme is present, the nitrophenylalanyl group is cleaved, with a concomitant increase in the sample's fluorescence. A variety of enzymes have been assayed by this type of procedure, including hydrolytic enzymes, other amino- and carboxypeptidases and an endopeptidase. Yaron et al. , Intramolecularly Quenched Fluoroqenic Substrates for Hydrolytic
Enzymes, Anal. Biochem. f__5, 229 (1979) ; Car el et al., Intramolecularly - Quenched Fluorescent Peptides as Fluoroqenic Substrates of Leucine Aminopeptidase and Inhibitors of Clostridial Aminopeptidase- Eur. J. Biochem.73., 617 (1977) ; Carmel et al., An
Intramolecularly Quenched Fluorescent Tripeptide as a Fluoroqenic Substrate of Angiotensin-I-Converting Enzyme and of Bacterial Dipeptidyl Carboxypeptidase, « Eur. J. Biochem. 87., 265 (1978) ; Florentin et al., A .Highly Sensitive Fluorometric Assay for
"Enkephalinase". a Neutral Metalloendopeptidase that Releases Tyrosine-Glvcine-Glvcine from Enkephalins, Anal. Biochem. 141, 62 (1984) . In each of the previous approaches, a synthetic substrate containing a quenching group and a fluorescing group was generated in order to detect the activity of the enzyme. An alternative to this approach would involve the synthesis of a resonance energy transfer pair of fluorescing groups on a substrate molecule. In this method, cleavage by the enzyme of one of the groups would result in a decrease in fluorescence, since the critical distance would be exceeded, eliminating the transfer of energy. However, the previously discussed approaches are limited to specifically designed substrates. Still another approach involves the estimation of a chromophore by fluorescence measurement. See . Blu berg et al. , Hemoglobin Determined in Whole Blood "Front Face" Fluorometry, Clin. Hemo. 2 _, 409 (1980) . Blumberg disclosed an assay based on attenuation of fluorescence of a dye, whose excitation wavelengths overlap with the absorption wavelengths of the chromophore.
Subsequently, M. Shaffer, U.S. Patent No. 4,495,293 (hereinafter Shaffer) filed a patent application disclosing a method to fluorometrically determine a ligand in an assay solution using conventional fluoro etric techniques. In Shaffer the intensity of the fluorescence emitted by the assay > solution is related to the change in trans issive properties of the assay solution produced by the interaction of;the ligand to be determined and a reagent system capable of producing change in the transmissive properties of the assay solution in the presence of the ligand. More particularly, Shaffer discloses a method to monitor absorbance using a fluorophore in solution with the chromophore. In this method the fluorophore may interact with the assay cocktail and produce changes in fluorescence intensity which are unrelated to the change being measured. The selection of the fluorophores is also restricted, in that pH dependent or environment sensitive fluorophores cannot be utilized. Additionally, when the fluorophore is in solution, less than accurate measure of absorbance may be obtained because light is absorbed exponentially through the chromophore sample. Similarly, Beggs & Sand, EPA 91,837 disclosed a solution based method for determination of tryptophan-deaminase activity by measuring the reduction in fluorescence in the presence of a chromophore produced by the interaction between indole pyruvic acid and metal ions using a fluorophore "whose fluorescence is capable of being quenched by the indole pyruvate-metal ion complex, the ions of the fluorophore being present throughout the incubation period".
Also, Sands, U.S. Patent No. 4,798,788 discloses a process to detect a nitrate reducing microorganism by measuring reduction of fluorescence in solution by causing the diazotization of the fluorophore. In all these cases a specific fluorophore needs to be chosen for each test to ensure that it will fluoresce under the conditions of the test, e.g. only few fluorophores fluoresce at pH of ,less than 2.0.
In addition to blood culture tests, a need exists to develop a noninvasive means to determine bacterial contamination of blood in a collection bag immediately prior to transfusion. Although, the previously discussed blood culture test can be used to determine bacterial contamination of transfusable blood, these test may result in errors. First, the transfusion bag must be later matched with a separate blood culture bottle sent to a test center to make a determination of potential microbial contamination prior to transfusion of the blood. This requirement for subsequent matching could result in errors. Additionally, blood culture bottles are cultured at higher temperature than the temperature that blood is normally stored; as such blood culture bottle tests yield an accelerated picture of bacterial contamination, while a test that simulates actual blood storage conditions may yield more accurate results.
Summary of the Invention This invention relates to a multi-layer body fluid culture sensor comprised of a pH sensitive absorbance based dye spectrally coupled to a pH insensitive, or pH sensitive dye that is highly buffered, fluorescence based dye. The pH sensitive absorbance based dye is encapsulated or isolated in a polymeric layer that is permeable to C02 and water, but impermeable to protons. The pH insensitive fluorophore is encapsulated or isolated in the second polymeric layer that may or may not be permeable to C02 and water. This type of sensor may be used to detect or determine the concentration of , microorganisms in bodily fluid. The spectral criterion required to make this determination are such that the absorption spectrum of the chromophore must overlap the excitation and/or emission spectrum of the fluorophore, thereby allowing the change in fluorescence to be related to the change in the reaction and consequently related to the presence or quantity of the substance of interest.
Further, this sensor is used to monitor microbial growth in collected transf sable blood. In particular, this sensor can be used to monitor bacterial growth in a collection bag of bodily fluid that is to be transfused into a patient. As bacteria grow they generate C02. The C02 generated by the bacteria diffuses into the polymeric layer that is in direct contact with a hydrated pH sensitive absorbance based dye. The C02 reacts with the aqueous environment to form carbonic acid (H2C03) , which lowers the pH of the absorbance dye environment. This results in a concomitant change in the pH sensitive spectrum of the dye. Typically, as the absorbance of an absorbance based dye decreases more light reaches the fluorophore for excitation which results in a larger amount of emitted fluorescence. The sensor is attached to a blood collection bag or separate sampler test bag. If a separate sampler bag is used this bag may contain microbial growth media or an inert substance such as a saline. With this system microbial contamination of transfusable blood in a collection bag can be determined immediately prior to transfusion. In one embodiment of this invention a detector, such as a handheld fluorescence detector, is used to monitor the - emitted fluorescence.
_ . Brief Description of the Figures
Fig. 1 shows a schematic diagram of a multi-layer blood culture sensor.
Fig.2 shows a blood culture growth curve detected by a xylenol blue-rhodamine 101 sensor. Fig. 3 shows a blood culture growth curve detected by xylenol blue in silicone-rhodamine B in acrylic sensor. Fig. 4 shows a blood culture growth curve for a xylenol blue in silicone-6213 acrylic sensor.
Fig. 5 shows a blood culture growth curve for a bromthymol blue in silicone-rhodamine 101 in silicone sensor.
Fig. 6 shows a sample test blood collection bag and fluorescent detector for monitoring growth of microorganisms in blood.
Fig. 7 shows the percent change of fluorescent intensity versus time for two blood samples.
Detailed Description - Best Mode In this approach, fluorescence from a fluorophore embedded in an inert light-transparent matrix, .is modulated by a pH sensitive absorbance dye embedded in a polymeric gas permeable, but proton impermeable matrix. The assay is carried out in a blood collection bag or sampler test blood collection bag. In a fluorometric based colorimetric assay the fluorescence intensity is regulated by changes in absorbance of an interfering chromophore. As a pH change occurs the chromophoric material alters the ,amount of emitted light reaching the fluorophore and/or the amount of emitted light reaching the detector. Spectrally compatible fluorescent and colorimetric indicators are selected so that as the pH changes due to the production of CO- by microorganisms present in the blood, the colorimetric indicators regulate the amount of light reaching the fluorophore and/or photodetector and, thus cause a change in the excitation and/or emission of the fluorescent dye. This change is detected with a fluorescent reader and can be correlated with the presence or concentration of microorganisms in the blood. A bodily fluid culture sensor is comprised of a pH sensitive absorbance based dye in or isolated by a polymeric gas permeable, but proton impermeable matrix, and a fluorescent dye in a second polymeric matrix. Spectrally compatible fluorescent and colorimetric indicators are selected so that when an organism is present in blood, the colorimetric indicator will regulate the amount of light reaching the fluorophore thereby causing a change in the emission intensity from the fluorescence dye reaching the photodetector. The change, indicating the presence of bacteria, is detected with a fluorometric reader.
More particularly, spectrally compatible fluorescence and absorbance dyes are selected dyes are selected so that as carbonic acid is produced (C02 and H20) , the absorbance of the dye will change thereby regulating the amount of light reaching the fluorophore and/or photodetector, thus producing a change in the measured fluorescence. This change is detected with a fluorescence reader. Spectrally compatible dyes are rhodamine B and xylenol blue. Additionally, bromthymol blue and rhodamine 101 are also spectrally compatible. For example this can be illustrated by inoculating a bag containing the appropriate growth media with Yersinia enterocolitica. As the organism grows, it produces C02 gas. The silicone is permeable to the C02. The C02 diffuses to the absorbance layer and reacts with water to produce carbonic acid (H2C03) . The carbonic acid causes a drop in the pH in the absorbance dye environment resulting in a change in measured absorbance. For example, as the pH drops in an absorbance layer containing the dye xylenol blue, the absorbance of xylenol blue decreases, thereby allowing more light to reach the fluorophore to excite it and thus increase the amount of fluorescence emitted at 590nm. A positive culture using xylenol blue as the absorbance dye is detected by increase the amount of fluorescence emitted at 590nm. A positive culture using xylenol blue as the absorbance dye is detected by a measured increase in fluorescence as the xylenol blue decreases in absorbance See Fig. 7.
. The pH sensitive absorbance based dye is encapsulated in or isolated by a polymeric matrix that is gas permeable, but proton impermeable. The polymeric matrix must be optically transparent in the visible region, permeable to gas, autoclavable, stable for at least six months, and proton impermeable. In particular, silicone may function as the polymeric matrix used to encapsulate or isolate the absorbance - based dye. Silicones found to meet these criteria , were Dow, Rhone Poulenc, G.E. and Wacker.
Similarly, the fluorescence based dyes can also be encapsulated in a polymeric matrix. The polymeric matrix used for the fluorophore does not have to meet all of the above requirements listed for the matrix used to encapsulate or isolate the absorbance dye. The similar features that it must possess are that it must be optically transparent in the visible region, autoclavable and stable for at least six months. The polymeric matrix containing or isolating the absorbance based dye must be coupled to the polymeric matrix containing the fluorescent dye. It should be noted that the polymeric matrices must be in close proximity so that light that has been regulated by the absorbance layer will have an effect on the emission intensity of the fluorophore as received by the photodetector. This can be accomplished by applying the same polymeric material to one side of each polymeric matrix and curing these matrices. Once the matrices containing the dyes have been adhered together they must be rehydrated. The clarity of the sensor upon rehydration is also a factor in matrix selection. In particular, in the present invention, a microorganism growth monitoring system for collected transfusable blood is shown in Fig. 6. The monitoring system shown in Fig. 6 is comprised of a sampler test blood collection bag 20. A bar code 28 can be attached to the bag to record data for later inspection. Blood from the blood collection bag to be transfused is expressed through tube 24 to sampler test blood collection bag 20. The wall of the blood collection bag contains a multi-layer sensor 22 .comprising a pH sensitive dye in a light transmissive, gas permeable, proton impermeable matrix and a pH insensitive fluorescence dye in inert light transparent matrix, said first and second matrices being spectrally coupled. The blood collection or blood storage bag can contain whole blood, plasma, serum, erythrocytes, red blood corpuscles, leukocytes, white blood corpuscles, thrombocytes and blood platelets, collectively referred to as blood storage. In the present invention the sensor can be located on the interior wall of the blood collection bag or a separate sampler test blood collection bag to which blood can be shunted for assessment. These various types of bags are heretofore collectively referred to as blood collection bag.
If a separate blood collection bag is employed the bag may contain a growth media or an inert substance such as saline. in the present invention the two-layer sensor is mounted inside a blood collection bag such that one layer, of the sensor is positioned facing outside the bag. The second layer which is fluorescent is positioned facing the interior of the bag. The sensor may be formed integrally with the wall of the bag. The invention, then, is comprised of the two-layer sensor outlined above, mounted inside a blood collection container in such a way that by utilizing a fluorometer to excite the fluorescent sensor and detect the emitted fluorescent light, a determination can be made as to the presence of a threshold level of microorganisms contained within the blood collection container.
An additional feature of this invention is ; that the bag is stored at normal blood storage temperatures, i.e. 4°C. In this environment certain microorganisms are not affected by the cold: Yersinia enterocolitica and Enterobacter agglomerans. Additionally, the system allows for the determination of other bacteria that would not normally grow rapidly in the cold but might be present in such high concentrations over time that it would be unsafe to transfuse into a patient: Citrobacter freundii; Pseudomonas aeruginosa; Staphylococcus aureus; and staphylococcus epidermidis. An alternative approach would follow the same design but would consist solely of an absorbance sensor. In this case the increase is C02 produced by the growing microorganisms and subsequent drop in pH would result in a visible color change in the sensor. This change in color visible to the blood handler, or detected by a colorimeter would signal that the blood contained a threshold level of microorganisms. Another feature of this invention involves covering the sensor with a gas permeable membrane to prevent naturally fluorescing substances in the blood from interacting with the fluorescent measurement.
In and alternative embodiment shown in Fig. 1, a bodily fluid culture sensor, is comprised of a pH sensitive absorbance based dye encapsulated in or isolated by a polymeric gas permeable, but proton impermeable matrix 4 and a fluorescent dye in a second polymeric matrix 2. Reflective surface 6 can be included to facilitate the transmission of light to the detecting element 12. In Fig. 1 interrogation light enters the sensor and is regulated by pH sensitive matrix 2 which in turn causes a change in ' the fluorescence emission 10 of the fluorophore in .matrix 4. This sensor offers the advantage of maximal surface.area.
A measurement is taken by first reading reference light intensity. Next the reading from the sensor disk is measured. The data is plotted by taking the ratio of reference, excitation light, to sample. In particular, as C02 levels increase in the blood collection bag, the absorbance of the absorbance dye changes, thereby changing the amount of light reaching the fluorescence layer and/or photodetector. This causes a change in emitted fluorescence that is detected. The following examples serve to illustrate the method of the present invention. The concentration of reagents and other variable parameters are only shown to exemplify the methods of the present invention and are not to be considered limitation thereof.
Example 1
At the time a unit of blood is drawn, an additional amount (10ml) is collected in such a manner as to be subsequently sectioned off from the unit to be transfused. This additional blood is then expressed through a tube into a flexible bag, attached to the blood collection bag. This side bag is supplied containing a microorganism growth media and an attached multi-layer sensor. The sensor is capable of detecting microorganism growth by measuring an increase in C02 production through a change in fluorescence emitted from the sensor.
After adding the additional blood to the bag containing media and the sensor, and waiting a predetermined amount of time (2 - 6 hours) for the sensor to equilibrate, an initial reading of the - sensor is made using a portable handheld fluorometer /to produce a baseline fluorescence level. This level can be manually,recorded for latter comparison or a bar code can be provided and attached to the bag. The blood and additional monitoring bag are then stored in a normal manner (4°C) .
At the time the blood is to be used for transfusion a second reading of the sensor is made and compared to the first reading. This is compared to the original reading. If a bar code was produced, the bar code and sensor are read. The instrument will compare the initial and final fluorescent values and based upon an established threshold level of change will signal negative or positive for growth. In this particular embodiment, the instrument will signal green for no growth or red for growth based on differences in original and final sensor readings.
Example 2 Xylenol Blue - Rhodamine 101 Sensor
Wacker silicone elastomer 3601 part A is thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended by the manufacturer. Next 5% w/w of a 50mM xylenol blue, dissolved in 5mM borate buffer pH 11 containing 1% Tween 80, is added to the silicone and homogenized to ensure a uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55"C for 2 hours.
Wacker silicone is prepared, as described above. Next 2% w/w of 7.5mM Rhodamine 101, in 50mM Tris-HCl buffer pH 8.5 in 95% ethylene glycol, is added to the silicone. The mixture is poured over the previously cured xylenol blue layer in the mold, - described above, and cured at 55°C overnight. This __ured, dehydrated, double layer sensor consists of two distinct layers., each 30/1000 of an inch thick. Disks may now be punched out of the mold and adhered onto the base of bottles using more silicone, ensuring that the absorbance layer is face down. Finally, the bottles are cured at 55°C for 15 minutes, rehydrated with normal saline and autoclaved on the wet cycle for 17 minutes. Saline is replaced with growth media and inoculated with E. coli by injecting a suspension with a sterile needle through the septum. The blood culture bottle is placed in the instrument and fluorescence emission is measured.
As the concentration of C02 increases in the blood culture bottle, the pH sensitive absorbance dye, Xylenol blue, the absorbance of the dye decreases, thus allowing more light to reach the fluorophore, Rhodamine 101, to thus increase the amount of fluorescence emitted at 590nM. This increase in fluorescence intensity v. time is shown in the blood culture growth curve at Fig. 2.
Example 3 Xylenol Blue in Silicone/Rhodamine B in Acrylic
Rhone Poulenc silicone elastomer 141 part A is thoroughly mixed with Rhone Poulenc 141 catalyst part B in a 10:1 ratio, as recommended by the manufacturer. Next 1% w/w of a lOOmM xylenol blue solution pH #11, dissolved in lOmM borate buffer containing 1% Tween 80, is added to the silicone and mixed thoroughly with a tongue blade to ensure uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch. The mold is allowed to sit out on the countertop at room temperature for about one hour or until the bubbles have disappeared, at which time the mold is placed in the incubator to cure at 55°C for two hours.
Rhone-Poulenc silicone is prepared, as described above. Next, a 40/1,000" thick acrylic disc (Glasflex, Inc.), approximately 1 cm in diameter, containing 0.2 grams/lb of rhodamine B (Sigma) is glued onto the above absorbance layer using the Rhone-Poulenc Silicone at the 10:1 ratio as glue. The double layer sensor is then placed back in the 55°C incubator for two hours to allow for adherence of the two layers. Following the curing, the double layer sensor is punched out with a cork borer, and glued onto the base of a Wheaton bottle, ensuring that the absorbance layer is face down, using the Rhone Poulenc silicone as mentioned above. The bottle is placed in the 55°C incubator to cure for at least two hours. The bottle is then rehydrated overnite and tested the following day as described in Example 1.
As the concentration of C02 increases in the blood culture bottle, the absorbance of the pH sensitive absorbance based dye xylenol blue decreases, thus allowing more light to reach the fluorophore (rhodamine B) doped acrylic, to thus increase the amount of fluorescence emitted at 590nm. This increase in fluorescence intensity v. time is shown in the blood culture growth curve in Fig. 3.
Example 4 Xylenol Blue in Silicone/6213 Red Standard Acrylic Wacker silicone elastomer 3601 part A is thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended with Wacker 3601 catalyst - part B in a 9:1 ratio, as recommended by the manufacturer. Next 5% w/w of a 50mM xylenol blue, dissolved in 5mM borate buffer pH 11 containing 1%
Tween 80, is added to the silicone and homogenized to ensure a uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55"C for two hours.
Next, a 40/1,000" thick acrylic disc (Glasflex, Inc.) , approximately 1 cm in diameter, referred to as No. 6213 Red (Glasfle:* Standard Product) is glued onto the above absorbance layer using the Wacker silicone at the 9:1 ratio as glue. The double layer sensor is then placed back in the 55"C incubator for two hours to allow for adherence of the two layers. Following the curing, the double layer sensor is punched out with a cork borer, and glued onto the base of a Wheaton bottle, ensuring that the absorbance layer is face down, using the Rhone Poulenc silicone as mentioned above. The bottle is placed in the 55°C incubator to cure for at least two hours. The bottle is then rehydrated overnite and tested the following day as described in Example 1.
As the concentration of C02 increases in the blood culture bottle, the absorbance of the pH sensitive absorbance based dye xylenol blue decreases, thus allowing more light to reach the fluorophore (rhodamine B) doped acrylic, to thus increase the amount of fluorescence emitted at 590nm. This increase in fluorescence intensity v. time is shown in the blood culture growth curve in Fig. 4.
Example 5 Bromthymol Blue in Silicone/Rhodamine 101 in Silicone
Wacker silicone elastomer 3601 part A is thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended by the manufacturer. Next 5% w/w of 50mM bromthymol blue, dissolved in 5mM tris buffer pH 12 in ethylene glycol, is added to the silicone and homogenized to ensure a uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55°C for two hours. Wacker silicone is prepared, as described above. Next 2% w/w of 7.5mM Rhodamine 101, in 50mM Tris-HCl buffer pH 8.5 in 95% ethylene glycol, is added to the silicone. The mixture is poured over the previously cured xylenol blue layer in the mold, described above to isolate the absorbance layer. This sensor is then cured at 55°C overnight. This cured, dehydrated, double layer sensor consists of two distinct layers, each 30/1000 of an inch thick. Disks may now be punched out of the mold and adhered onto the base of bottles using more silicone, ensuring that the absorbance layer is face down. Finally, the bottles are cured at 55"C for 15 minutes, rehydrated with normal saline and autoclaved on the wet cycle for 17 minutes. Saline is replaced with growth media and inoculated with E. coli by injecting a suspension with a sterile needle through the septum. The blood culture bottle is placed in the instrument and fluorescence emission is measured. The increase in fluorescence intensity v. time is shown in blood culture growth curve in Fig. 5.
Although this invention has been described with respect to specific embodiments, the details > thereof are not to be construed as limitations, for it will be apparent that various equivalents, changes and modifications may be resorted to without departing from the spirit and scope thereof and it is understood that such equivalent embodiments are intended to be included herein.

Claims

WHAT IS CLAIMED IS:
1. A microorganism growth monitoring apparatus for collected bodily fluid to be transfused into a patient comprising: a. a flexible bag; b. means to add said bodily fluid to said bag; c. a sensor for detecting microbial growth in said bag, said sensor comprising a pH sensitive absorbance based dye encapsulated in a light transmissive, gas permeable, proton impermeable matrix, and a pH insensitive fluorescent dye in an inert light transparent matrix, said first and second matrices being spectrally coupled, said . sensor being attached to the inside wall of said bag.
2. The apparatus of claim 1 wherein said bag is a blood collection bag.
3. The apparatus of claim 2 wherein said bag is a sample test bag.
4. A method to detect microbial growth, in collected bodily fluid to be transfused into a patient, in a flexible bag containing a microbial growth sensor attached to the inside of said bag comprising: a. adding said bodily fluid to said bag; b. storing said bag at about 4°C for a sufficient period of time to allow for microbial growth; c. detecting microbial growth to obtain a baseline reading of growth using said sensor; d. detecting microbial growth in said bag prior to transfusion to obtain reading prior to transfusion; e. comparing said baseline reading to said reading prior to transfusion to determine if microbial growth has occurred in said bodily fluid.
5. The method of claim 4 wherein said microbial growth sensor is comprised of a pH sensitive absorbance based dye encapsulated in a light transmissive, gas permeable, proton impermeable matrix, and a pH insensitive fluorescent dye in an
- inert light transparent matrix, said first and second matrices being spectrally coupled.
6. , The method of claim 4 wherein said microbial growth is detected by measuring an increase in C02 production through a change in fluorescence emitted from said sensor.
7. The method of claim 6 wherein a handheld fluorometer is used to detect changes in emitted fluorescence.
8. The method of claim 4 wherein said bag is a blood collection bag. 9. The method of claim 4 wherein said bag is a sample test bag.
10. The method of claim 9 wherein said bag contains bacterial growth media.
11. The method of claim 9 wherein said bag contains an inert substance.
12. The method of claim 4 wherein said fluid is blood.
13. A noninvasive method to detect microbial growth in a flexible bag comprising: a. adding blood to a said bag containing a sensor for C02 production; b. means to noninvasively monitor said sensor to determine microbial growth.
14. The method of claim 13 wherein said sensor emits fluorescence light upon interrogation with a fluorometer as a function of microbial growth.
15. The method of claim 13 wherein said sensor changes color in response to microbial growth.
EP92911615A 1991-05-08 1992-04-29 Method and apparatus to detect bacterial contamination of transfusable blood Withdrawn EP0538450A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69708091A 1991-05-08 1991-05-08
US697080 1991-05-08

Publications (2)

Publication Number Publication Date
EP0538450A1 EP0538450A1 (en) 1993-04-28
EP0538450A4 true EP0538450A4 (en) 1994-04-06

Family

ID=24799702

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92911615A Withdrawn EP0538450A1 (en) 1991-05-08 1992-04-29 Method and apparatus to detect bacterial contamination of transfusable blood

Country Status (5)

Country Link
EP (1) EP0538450A1 (en)
JP (1) JPH05508556A (en)
AU (1) AU1915892A (en)
CA (1) CA2086608A1 (en)
WO (1) WO1992019764A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601997A (en) 1995-02-03 1997-02-11 Tchao; Ruy Chemotaxis assay procedure
US5843699A (en) * 1997-04-08 1998-12-01 Difco Laboratories, Inc. Rapid microorganism detection method
GB2339903A (en) * 1998-07-23 2000-02-09 Fsm Technologies Ltd Fluid container
EP1122535A3 (en) * 2000-01-31 2004-09-22 The Penn State Research Foundation Interrogation of changes in the contents of a sealed container
US20040058453A1 (en) * 2002-09-20 2004-03-25 3M Innovative Properties Company Reaction pouch comprising an analytical sensor
DE102007013736B4 (en) * 2007-03-22 2011-05-12 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Method for detecting bacteria in blood-derived samples by oxygen concentration determination
US9322046B2 (en) * 2010-11-01 2016-04-26 3M Innovative Properties Company Biological sterilization indicator
US20140170699A1 (en) * 2011-05-12 2014-06-19 Abbott Laboratories Test for detecting spoilage in a flexible packet
GB201120991D0 (en) 2011-12-07 2012-01-18 Univ Manchester Microsensor
WO2014012584A1 (en) * 2012-07-18 2014-01-23 Siemens Aktiengesellschaft Analysis device for examining a fluid in a flexible sac and reaction container having a wall made of a flexible material
JP2016518152A (en) * 2013-03-13 2016-06-23 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Chemochromic medical device
JP6020513B2 (en) * 2014-05-29 2016-11-02 横河電機株式会社 Cell culture bag and method for producing cell culture bag
US10907126B2 (en) 2016-03-01 2021-02-02 Asp Global Manufacturing Gmbh Self-contained biological indicator
US11242505B2 (en) 2017-01-03 2022-02-08 Asp Global Manufacturing Gmbh Self-contained biological indicator
US11053534B2 (en) 2017-06-30 2021-07-06 Asp Global Manufacturing Gmbh Systems and methods for confirming activation of biological indicators
US11248250B2 (en) 2017-12-01 2022-02-15 Asp Global Manufacturing Gmb Self-contained biological indicator
CN113125656B (en) * 2020-01-16 2023-07-04 中国农业科学院农业信息研究所 Intelligent fruit bag for monitoring fruit growth
MX2023005304A (en) 2020-11-10 2023-06-23 Advanced Sterilization Products Inc Ampoule breaker for a biological indicator.
CN115327111A (en) * 2022-07-29 2022-11-11 厦门宝太生物科技股份有限公司 Immunochromatography test strip with variable color indication and use method thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3676679A (en) * 1970-04-22 1972-07-11 Johnston Lab Inc Apparatus for detecting biological activity
US4073691A (en) * 1976-08-24 1978-02-14 Johnston Laboratories, Inc. Method for detecting the presence of biologically active agents
US4182656A (en) * 1976-09-10 1980-01-08 Johnston Laboratories, Inc. Method for detecting the presence of biologically active agents utilizing 13 C-labeled substrates
US4152213A (en) * 1977-03-10 1979-05-01 Johnston Laboratories, Inc. Vacuum detection of bacteria
GB1601689A (en) * 1977-07-15 1981-11-04 Mariel C Method of diagnosing bacteremia and apparatus therefor
DE3026089A1 (en) * 1980-07-10 1982-06-09 Hans Günter Priv.Doz. Dr.med. 6900 Heidelberg Nöller FLASH PHOTOMETER FOR NEPHELOMETRIC AND FLUOROMETRIC APPLICATIONS
JPH0611237B2 (en) * 1982-04-14 1994-02-16 ラジオメーター コーポレイト ディベロップメント リミテッド Microbiological test method
AU564610B2 (en) * 1982-08-31 1987-08-20 Becton Dickinson & Company Detecting biological activity by infrared analysis
US4557900A (en) * 1982-09-28 1985-12-10 Cardiovascular Devices, Inc. Optical sensor with beads
AT379688B (en) * 1982-11-22 1986-02-10 List Hans SENSOR ELEMENT FOR DETERMINING THE O2 CONTENT OF A SAMPLE
AT377095B (en) * 1982-11-23 1985-02-11 List Hans SENSOR ELEMENT FOR DETERMINING THE O2 CONTENT OF A SAMPLE AND METHOD FOR PRODUCING THE SAME
AT380957B (en) * 1982-12-06 1986-08-11 List Hans SENSOR ELEMENT FOR FLUORESCENT OPTICAL MEASUREMENTS, AND METHOD FOR THE PRODUCTION THEREOF
CA1261717A (en) * 1982-12-23 1989-09-26 John R. Bacon Method and apparatus for oxygen determination
GB8303096D0 (en) * 1983-02-04 1983-03-09 Oxoid Ltd Bacterial testing
US4495293A (en) * 1983-02-24 1985-01-22 Abbott Laboratories Fluorometric assay
SE439927B (en) * 1984-02-10 1985-07-08 Sangtec Medical Ab DEVICE AND PROCEDURE FOR REGISTRATION OF BACTERIAL EVENTS, SPECIFICALLY UNDER FIELD CONDITIONS
GB8416045D0 (en) * 1984-06-22 1984-07-25 Unilever Plc Carrying out microchemical and microbiological tests
GB8416044D0 (en) * 1984-06-22 1984-07-25 Unilever Plc Carrying out microchemical and microbiological tests
JPS61186854A (en) * 1985-02-14 1986-08-20 Fuji Photo Film Co Ltd Instrument for measuring number of bacteria in ultra-pure water
US4653907A (en) * 1985-06-11 1987-03-31 Freundlich Lawrence F Blood culture bottle examining instrument
US4824789B1 (en) * 1986-10-10 1996-08-13 Minnesota Mining & Mfg Gas sensor
US4867919A (en) * 1986-10-10 1989-09-19 Minnesota Mining And Manufacturing Company Method of making a gas sensor
US4772558A (en) * 1987-06-01 1988-09-20 Ranier Hammann Blood culture system
US4780191A (en) * 1987-06-26 1988-10-25 Massachusetts Institute Of Technology L-glutamine sensor
US4945060A (en) * 1988-03-15 1990-07-31 Akzo N. V. Device for detecting microorganisms
US5094955A (en) * 1988-03-15 1992-03-10 Akzo N.V. Device and method for detecting microorganisms

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
C. BURNEY: "A subsurface flexible plasic enclosure for the in situ study of short term microbiological and chemical dynamics", LIMNOLOGY AND OCEANOGRAPHY, vol. 29, no. 5, 1 July 1984 (1984-07-01), WASHINGTON DC USA, pages 1140 - 1144 *
See also references of WO9219764A1 *

Also Published As

Publication number Publication date
AU1915892A (en) 1992-12-21
JPH05508556A (en) 1993-12-02
EP0538450A1 (en) 1993-04-28
WO1992019764A1 (en) 1992-11-12
CA2086608A1 (en) 1992-11-09

Similar Documents

Publication Publication Date Title
EP0538450A4 (en)
Hoppe Use of fluorogenic model substrates for extracellular enzyme activity (EEA) measurement of bacteria
US4945060A (en) Device for detecting microorganisms
US5164301A (en) Process and kit for detecting microbial metabolism
US5372784A (en) Measurement of bacterial CO2 production in an isolated fluorophore by monitoring an absorbance regulated change of fluorescence
US5217876A (en) Method for detecting microorganisms
KR0183402B1 (en) Device and method for detecting microorganisms
JP3043063B2 (en) Precipitation test for microorganisms
US5856175A (en) Device for detecting microorganisms
US5164796A (en) Apparatus and method for detection of microorganisms
EP0507930B1 (en) Measurement of color reactions by monitoring a change of fluorescence
US5266486A (en) Method and apparatus for detecting biological activities in a specimen
US5217875A (en) Method for detecting biological activities in a specimen and a device for implementing the method
CA2497555C (en) Detection of biological molecules by differential partitioning of enzyme substrates and products
EP0472622B1 (en) Apparatus for detection of microorganisms
AU652423B2 (en) Measurement of bacterial CO2 production in an isolated fluorophore by monitoring an absorbance regulated change of fluorescence
US4798788A (en) Processes and materials for carrying out microchemical and microbiological tests
US20240175819A1 (en) Diagnostic test
Wang et al. A fluorometric rate assay of hydrogen peroxide using immobilized peroxidase with a fibre-optic detector

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19940216

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE

17Q First examination report despatched

Effective date: 19940912

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19950124